BriaCell Therapeutics Corp. (BCTX)

NASDAQ: BCTX · Real-Time Price · USD

2.770

+0.030 (1.09%)

At close: Jun 12, 2026, 4:00 PM EDT

2.780

+0.010 (0.36%)

After-hours: Jun 12, 2026, 6:52 PM EDT

BriaCell Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is August - July.

Millions USD. Fiscal year is Aug - Jul.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021
Cash & Equivalents	6.88	10.49	0.86	21.25	41.04	57.27
Short-Term Investments	15.92	7.37	-	-	-	-
Cash & Short-Term Investments	22.8	17.87	0.86	21.25	41.04	57.27
Cash Growth	83.02%	1972.44%	-95.94%	-48.22%	-28.34%	269412.45%
Accounts Receivable	2.59	2.06	2.79	5.7	0.02	0.01
Other Current Assets	-	-	-	-	1.28	0.52
Total Current Assets	25.39	19.93	3.65	26.95	42.35	57.8
Net Property, Plant & Equipment	0.35	0.3	0.39	-	-	-
Other Intangible Assets	0.17	0.18	0.2	-	0.23	0.25
Long-Term Investments	0.75	0.52	0.42	0.22	0	0
Other Long-Term Assets	0.41	0.72	1.21	-	-	-
Total Assets	27.07	21.65	5.87	27.16	42.58	58.04
Accounts Payable	2.17	3.28	7.17	1.12	0.46	0.21
Accrued Expenses	1.42	0.69	0.29	0.68	0.48	0.34
Total Current Liabilities	3.59	3.98	7.46	1.8	0.94	0.56
Other Long-Term Liabilities	0.07	0.34	1.1	29.14	31.31	29.82
Total Long-Term Liabilities	0.07	0.34	1.1	29.14	31.31	29.82
Total Liabilities	3.66	4.32	8.56	30.94	32.25	30.37
Common Stock	117.12	101.74	72.17	69.59	65.59	54.77
Additional Paid-in Capital	41.42	28.04	11.03	7.42	5.23	2.18
Accumulated Other Comprehensive Income	-0.14	-0.14	-0.14	-0.14	-0.14	-0.14
Retained Earnings	-134.34	-111.76	-85.44	-80.65	-60.35	-29.14
Total Common Shareholders' Equity	24.06	17.88	-2.38	-3.78	10.33	27.67
Minority Interest	-0.65	-0.55	-0.3	-	-	-
Shareholders' Equity	23.41	17.33	-2.68	-3.78	10.33	27.67
Total Liabilities & Equity	27.07	21.65	5.87	27.16	42.58	58.04
Net Cash (Debt)	22.8	17.87	0.86	21.25	41.04	57.27
Net Cash Growth	27.64%	1972.44%	-95.94%	-48.22%	-28.34%	-
Net Cash Per Share	7.12	42.23	7.86	204.08	397.33	1900.69
Book Value	24.06	17.88	-2.38	-3.78	10.33	27.67
Book Value Per Share	7.51	42.26	-21.72	-36.27	100.00	918.39
Tangible Book Value	23.89	17.7	-2.58	-3.78	10.1	27.43
Tangible Book Value Per Share	7.46	41.82	-23.54	-36.27	97.77	910.24

SEC Filings: 10-K · 10-Q